Toxicity and medical countermeasure studies on the organophosphorus nerve agents VM and VX
Author(s) -
Matthew E. Price,
Christopher H. Dalton,
S. J. Graham,
A. Christopher Green,
John Jenner,
H.J. Groombridge,
Christopher M. Timperley
Publication year - 2015
Publication title -
proceedings of the royal society a mathematical physical and engineering sciences
Language(s) - English
Resource type - Journals
eISSN - 1471-2946
pISSN - 1364-5021
DOI - 10.1098/rspa.2014.0891
Subject(s) - nerve agent , toxicity , in vivo , soman , toxicology , median lethal dose , guinea pig , acute toxicity , pharmacology , chemistry , medicine , biology , biochemistry , microbiology and biotechnology , organic chemistry , acetylcholinesterase , enzyme
To support the effort to eliminate the Syrian Arab Republic chemical weapons stockpile safely, there was a requirement to provide scientific advice based on experimentally derived information on both toxicity and medical countermeasures (MedCM) in the event of exposure to VM, VX or VM–VX mixtures. Complementary in vitro and in vivo studies were undertaken to inform that advice. The penetration rate of neat VM was not significantly different from that of neat VX, through either guinea pig or pig skin in vitro . The presence of VX did not affect the penetration rate of VM in mixtures of various proportions. A lethal dose of VM was approximately twice that of VX in guinea pigs poisoned via the percutaneous route. There was no interaction in mixed agent solutions which altered the in vivo toxicity of the agents. Percutaneous poisoning by VM responded to treatment with standard MedCM, although complete protection was not achieved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom